YSS (TSXV:YSS,WKN:A2PMAX) received its 11th cannabis retail license from the Alberta Gaming, Liquor and Cannabis Commission (AGLC) under the YSSTM operating brand.
As quoted in the press release:
YSS expects all eleven stores to be opened in Q3 2019 and to materially contribute to the Company’s financial and operating results for the second half of 2019.
The retail cannabis license received is for the YSS Spruce Grove store, conveniently located on the corner of two busy regional highways, Jennifer Heil Way and Parkland Highway.
YSS currently has four operating retail stores in Calgary and Red Deer. YSS expects to open seven additional retail cannabis stores during Q3 2019. One further YSS retail location in Edmonton has completed inspections by the AGLC and is pending license. Below is an outline of the seven stores expected to be opened in the coming weeks:
“We continue to be pleased with AGLC’s progressive approach to issuing cannabis retail licenses, the growth in cannabis supply and the results from our operating stores,” said Theo Zunich, President and CEO of YSS. “We are excited at the growth profile ahead for YSS as we continue to build out our strategic portfolio of Alberta locations.”
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).